In the current issue of @BloodJournal we describe for the first time how TCRmimic CAR T cells can target peptide:MHC ligands that are not recognized by regular T cells.

Online Now: Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future dlvr.it/SXgvBg

Excited to present our data from our investigator initiated trial in ATLL at #ASH22 ASH University of Miami Sylvester Comprehensive Cancer Center HTLV Aware HTLV.net . Stay tuned!

Today is #WorldAIDSDay. Did you know some of the earliest AIDS patient care and research was performed by NCI scientists and external researchers funded by NCI? Find out how #CancerResearch led to #AIDS breakthroughs-cancer.gov/about-nci/orga… @hivgov @cdc_hiv

CRISPR screens for functional interrogation of immunity dlvr.it/Sf3vQs

NEW Review: CRISPR screens for functional interrogation of immunity bit.ly/3hdISIQ by Hao Shi, Hongbo Chi & @JohnDoench discusses recent applications of CRISPR screening of immune cells in infection, inflammation and cancer

Celebrating #ASH22 with the leukemia ✨dream✨ team Justin Watts MD Terrence Bradley Namrata Chandhok Mikkael A. Sekeres MD, MS and of course Georgios Pongas, MD with the guest appearance!

Thanks to the support of Wendy and Theo Kolokotrones, Dr. Alana L. Grajewski was recently presented with the Kolokotrones Endowed Chair in #Ophthalmology, one of the most prestigious academic honors a faculty member can receive. Bascom Palmer Eye Institute loom.ly/CofJlyQ

Gift Basket from a patient in clinic today! Humbled and inspired by the courage of our patients! This quote made me laugh :-)

It was so much fun presenting the interim results of our IIT in ATLL! An amazing venue organised #DAVABermudaHeme !

IWMF Proudly Announces Funding WM-NET Clinical Trials Network in collaboration with Dana-Farber! Read more about this exciting research update: conta.cc/46hd09u

Important study demonstrating how combination of anti-hypertensive medications can decrease the blood pressure in CLL patients treated with ibrutinib published Blood Advances. It was fun working with Laura Samples, MD and Mazyar Shadman, MD MPH !

Extremely proud of our Miller Medicine Sylvester Comprehensive Cancer Center Hematology Fellows Ali Al Sbihi, MD and Mariam Bird for publishing our review manuscript describing the latest advances of ADC in lymphoid malignancies mdpi.com/2682010 #mdpicancers via Cancers MDPI

An international brain trust of WM thought leaders are in NYC for the IWMF/LLS Strategic Research Roadmap and WM-Net Summit. This distinguished group is uncovering the most promising research pathways to a cure for WM and strengthening clinical research collaboration.

Our latest study describing the distinctive genomic features of HTLV1 related ATLL in Western populations ⁦Miller Medicine⁩ ⁦Sylvester Comprehensive Cancer Center⁩. A multiomic approach to gain deeper understanding of a challenging virus driven lymphoid malignancy pubmed.ncbi.nlm.nih.gov/39113648/

In this interesting case report, we describe a patient with CLL who presented with hyperviscocity syndrome due to IgM paraproteinemia Miller Medicine Jackson Health System . Successful Treatment of a CLL associated IgM Hyper-viscosity Syndrome:... sciencedirect.com/science/articl…

Our recent review manuscript describing the latest Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies mdpi.com/2990414 #mdpicancers via Cancers MDPI Miller Medicine Sylvester Comprehensive Cancer Center CLL Society Inc.

In our latest publication Blood Advances, we report high rate of complete responses induced by platinum-based regimen with BTK inhibitors in Richter's Syndrome. Sylvester Comprehensive Cancer Center Miller Medicine CLL Society Inc. ashpublications.org/bloodadvances/…